Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells

Citation
G. Govindarajan et al., Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells, CIRCUL RES, 87(8), 2000, pp. 710-716
Citations number
31
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
CIRCULATION RESEARCH
ISSN journal
00097330 → ACNP
Volume
87
Issue
8
Year of publication
2000
Pages
710 - 716
Database
ISI
SICI code
0009-7330(20001013)87:8<710:FAKIII>2.0.ZU;2-B
Abstract
The rate of vascular smooth muscle cell protein synthesis and cellular hype rtrophy in response to angiotensin II (Ang II) is dependent on activation o f protein tyrosine kinases (PTKs) and both the extracellular signal-regulat ed kinase (ERK) 1/2 and p70(S6K) pathways. One potential PTK that may regul ate these signaling cascades is focal adhesion kinase (FAK), a nonreceptor PTK associated with focal adhesions. We used an actin depolymerizing agent, cytochalasin D (Cyt-D), and a replication-defective adenovirus encoding FA K-related nonkinase (FRNK), an inhibitor of FAK-dependent signaling, as too ls to assess whether FAK was upstream of the ERK1/2 and/or the p70(S6K) pat hways. Cyt-D reduced basal FAK phosphorylation and blocked Ang II-dependent FAK phosphorylation in a dose-dependent manner. Confocal microscopy indica ted that Cyt-D induced actin filament disruption and FAK delocalization fro m focal adhesions. Cyt-D also reduced Ang II-induced ERK1/2 activation, but p70(S6K) activation was relatively unaffected. Cyt-D reduced basal protein synthetic rate and substantially reduced the Ang II-induced increase in pr otein synthesis. Similarly, FRNK overexpression blocked Ang II-induced FAK phosphorylation and ERK1/2 activation, but not p70S6K phosphorylation, and markedly inhibited protein synthesis. This is the first report to demonstra te that FAK is a critical component of the signal transduction pathways tha t mediate Ang II-induced ERK1/2 activation, c-fos induction, and enhanced p rotein synthesis in vascular smooth muscle cells.